ArticleThe review of diabetic studies : RDS2008

Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors.

Richard E Pratley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.